Becotatug Vedotin (MRG003) in Previously Treated Advanced Hepatocellular Carcinoma

Clinical trial NCT07536789 · RECRUITING

Trial details

NCT number: NCT07536789
Sponsor: Fudan University
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Hepato Cellular Carcinoma (HCC)

Start date: 2026-04-17
Primary completion: 2028-04-15
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.